DICOT — Dicot Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK664.75m
- SEK608.55m
- SEK0.16m
Brief: Dicot Pharma Gets FDA Clearance To Start First Part Of Phase 2B Study With Lib-01 In U.S.
Brief: Dicot Pharma Announces Outcome In Oversubscribed Rights Issue
Brief: Dicot Pharma Announces Prelim Rights Issue Outcome
Brief: Dicot Pharma Submits IND Application To FDA
Brief: Dicot Pharma Resolves On Rights Issue Of About SEK 210 Mln
Brief: Dicot Pharma B - Q1 Net Sales Amount To Sek 0.0 Million
Brief: Dicot To Carry Out Rights Issue Of SEK 210 Million
Brief: Dicot Pharma Q4 Net Sales Of 0.0 Msek
Brief: Dicot Pharma Signs Agreement With CRO Ahead Of Phase 2B Study With Lib-01
Brief: Dicot Pharma Submits Patent Application For LIB-01
Brief: Dicot Pharma Q3 Loss After Financial Items SEK 16.1 Mln
Brief: Dicot Pharma Announces Positive Results From Its Phase 2A Study
Brief: Dicot Pharma Q2 Loss After Financial Items At SEK 24.3 Mln
Brief: Dicot Pharma Says No Dividend To Be Paid For The Year
Brief: Dicot Pharma Q1 Net Sales Flat At SEK 0.0 Mln
Brief: Dicot Pharma's TO 6 Provides Company SEK 43.8 Mln
Brief: Dicot Pharma Q4 Net Sales Flat At SEK 0.0 Million
Brief: Dicot Q3 EPS SEK -0.01
Brief: Dicot Pharma Gets Conditional Approval For Listing On Nasdaq First North Growth Market